Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome | MicrobiomeTrials← Back to trialsNCT00482794
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
RecruitingOBSERVATIONAL
Trial Details
Start: 2006-06Est. Completion: 2029-03
Enrollment target: 2,800 participants Locations- Duke University Medical Center, Durham, North Carolina, United States
Other microbiome trials you might be interested in
COVID-19
In January 2020, researchers isolated and sequenced in China from patients with severe atypical pneumonia a novel corona…
Amiens, FranceEst. completion Jun 2026
Deep Vein ThrombosisAtrial FibrillationPost-Myocardial Infarction SyndromePulmonary EmbolismArtificial Heart Device UserThrombophiliaAntiphospholipid Syndrome
Comparison of capillary whole blood INR determined by LumiraDx Instrument to venous plasma INR determined by laboratory …
Glasgow, United KingdomCompleted Nov 23, 2018
Antiphospholipid Syndrome (APS)Thrombosis
This is a Phase I, open-label, dose escalation, multicenter study to evaluate the safety, tolerability, preliminary effi…
Beijing, ChinaEst. completion Sep 30, 2027